Exelixis
EXEL
#1647
Rank
NZ$18.21 B
Marketcap
$63.79
Share price
-0.96%
Change (1 day)
72.61%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: $86.79 NZD on 2000-07-26

Lowest end of day price: $2.27 NZD on 2014-12-24

Stock price history of Exelixis from 2000 to 2025

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
$58.91-0.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
$89.41 0.00%๐Ÿ‡ซ๐Ÿ‡ท France
$172.55-2.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$99.19-0.16%๐Ÿ‡บ๐Ÿ‡ธ USA
$479.51 0.99%๐Ÿ‡บ๐Ÿ‡ธ USA
$259.10-0.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$46.35-0.72%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.80 3.46%๐Ÿ‡บ๐Ÿ‡ธ USA
$26.43 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA